(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.
The three biggest winners today are Telefonica, SmileDirectClub, and Xenetic Biosciences.
| Rank | Financial Asset | Price | Premarket Change |
Updated (EST) |
|---|---|---|---|---|
| 1 | Telefonica (TEF) | 3.95 | 3.4% | 2023-02-14 07:19:22 |
| 2 | SmileDirectClub (SDC) | 0.60 | 3.35% | 2023-02-14 07:33:45 |
| 3 | Xenetic Biosciences (XBIO) | 0.60 | 3.28% | 2023-02-14 07:33:14 |
| 4 | Inovio Pharmaceuticals (INO) | 1.58 | 3.27% | 2023-02-14 07:27:49 |
| 5 | Orange (ORAN) | 10.72 | 2.49% | 2023-02-14 07:25:03 |
| 6 | Aurora Cannabis (ACB) | 0.93 | 1.63% | 2023-02-14 07:06:46 |
| 7 | Ericsson (ERIC) | 5.77 | 1.58% | 2023-02-14 06:51:23 |
| 8 | CarMax (KMX) | 76.29 | 1.58% | 2023-02-14 06:44:43 |
| 9 | Lloyds Banking Group (LYG) | 2.61 | 1.56% | 2023-02-14 07:00:18 |
| 10 | FuboTV (FUBO) | 2.10 | 1.45% | 2023-02-14 07:21:40 |
The three biggest losers today are Cronos Group, Niu Technologies, and Lumen Technologies.
| Rank | Financial Asset | Price | Premarket Change |
Updated (EST) |
|---|---|---|---|---|
| 1 | Cronos Group (CRON) | 2.25 | -1.75% | 2023-02-14 06:46:58 |
| 2 | Niu Technologies (NIU) | 4.60 | -1.5% | 2023-02-14 06:48:01 |
| 3 | Lumen Technologies (LUMN) | 4.01 | -1.23% | 2023-02-14 07:06:52 |
| 4 | Amicus Therapeutics (FOLD) | 12.55 | -0.71% | 2023-02-14 07:26:54 |
| 5 | BCE (BCE) | 45.60 | -0.5% | 2023-02-14 04:10:12 |
| 6 | ImmunoGen (IMGN) | 4.33 | -0.46% | 2023-02-14 05:13:14 |
| 7 | Cigna (CI) | 298.00 | -0.19% | 2023-02-14 04:21:18 |
| 8 | Cigna (CI) | 298.00 | -0.19% | 2023-02-14 04:21:18 |
| 9 | CNH Industrial (CNHI) | 16.39 | -0.12% | 2023-02-14 04:21:28 |
| 10 | United Airlines (UAL) | 49.15 | -0.08% | 2023-02-14 07:19:14 |
Premarket Winners today
1. Telefonica (TEF) – Premarket: 3.4%
Telefónica, S.A., together with its subsidiaries, provides telecommunications services in Europe and Latin America. The company's mobile and related services and products comprise mobile voice, value added, mobile data and Internet, wholesale, corporate, roaming, fixed wireless, and trunking and paging services. Its fixed telecommunication services include PSTN lines; ISDN accesses; public telephone services; local, domestic, and international long-distance and fixed-to-mobile communications; corporate communications; supplementary value-added services; video telephony; intelligent network; and telephony information services, as well as leases and sells handset equipment. The company also provides Internet and broadband multimedia services comprising Internet service provider, portal and network, retail and wholesale broadband access, narrowband switched access, high-speed Internet through fibre to the home, and voice over Internet protocol services. In addition, it offers leased line, virtual private network, fibre optics, web hosting and application, outsourcing and consultancy, desktop, and system integration and professional services. Further, the company offers wholesale services for telecommunication operators, including domestic interconnection and international wholesale services; leased lines for other operators; and local loop leasing services, as well as bit stream services, wholesale line rental accesses, and leased ducts for other operators' fiber deployment. Additionally, it provides video/TV services; smart connectivity and services, and consumer IoT products; financial and other payment, security, cloud computing, advertising, big data, and digital telco experience services; virtual assistants; digital home platforms; and Movistar Home devices. It also offers online telemedicine, home insurance, music streaming, and consumer loan services. The company was incorporated in 1924 and is headquartered in Madrid, Spain.
NYSE ended the session with Telefonica jumping 0.13% to $3.82 on Tuesday, after four consecutive sessions in a row of gains. NYSE jumped 0.89% to $16,052.25, after two sequential sessions in a row of gains, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, Telefonica has a trailing twelve months EPS of $0.289.
PE Ratio
Telefonica has a trailing twelve months price to earnings ratio of 13.2. Meaning, the purchaser of the share is investing $13.2 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.96%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.3%, now sitting on 40.23B for the twelve trailing months.
Volatility
Telefonica’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.57%, a negative 0.23%, and a positive 1.24%.
Telefonica’s highest amplitude of average volatility was 1.33% (last week), 1.24% (last month), and 1.24% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Telefonica’s stock is considered to be oversold (<=20).
Moving Average
Telefonica’s value is above its 50-day moving average of $3.71 and below its 200-day moving average of $4.11.
More news about Telefonica.
2. SmileDirectClub (SDC) – Premarket: 3.35%
SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment with a network of approximately 250 licensed orthodontists and general dentists through its teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.
NASDAQ ended the session with SmileDirectClub rising 3.3% to $0.58 on Tuesday, after two consecutive sessions in a row of gains. NASDAQ rose 1.48% to $11,891.79, following the last session’s upward trend on what was an all-around bullish trend trading session today.
Earnings Per Share
As for profitability, SmileDirectClub has a trailing twelve months EPS of $-2.334.
Yearly Top and Bottom Value
SmileDirectClub’s stock is valued at $0.58 at 07:34 EST, way below its 52-week high of $3.10 and way above its 52-week low of $0.32.
Volatility
SmileDirectClub’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.78%, a negative 0.62%, and a positive 7.01%.
SmileDirectClub’s highest amplitude of average volatility was 6.00% (last week), 6.21% (last month), and 7.01% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth declined by 27.8%, now sitting on 541.41M for the twelve trailing months.
Sales Growth
SmileDirectClub’s sales growth is negative 28.2% for the current quarter and negative 22.1% for the next.
More news about SmileDirectClub.
3. Xenetic Biosciences (XBIO) – Premarket: 3.28%
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. It is also leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
NASDAQ ended the session with Xenetic Biosciences sliding 4.03% to $0.58 on Tuesday, after five successive sessions in a row of losses. NASDAQ rose 1.48% to $11,891.79, following the last session’s upward trend on what was an all-around positive trend exchanging session today.
Earnings Per Share
As for profitability, Xenetic Biosciences has a trailing twelve months EPS of $-1.704.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -59.34%.
Moving Average
Xenetic Biosciences’s worth is way higher than its 50-day moving average of $0.40 and below its 200-day moving average of $0.64.
More news about Xenetic Biosciences.
4. Inovio Pharmaceuticals (INO) – Premarket: 3.27%
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, such as head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, including recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); and Lassa fever. Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800 for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.
NASDAQ ended the session with Inovio Pharmaceuticals falling 3.48% to $1.53 on Tuesday while NASDAQ rose 1.48% to $11,891.79.
Earnings Per Share
As for profitability, Inovio Pharmaceuticals has a trailing twelve months EPS of $-1.073.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -87.99%.
Sales Growth
Inovio Pharmaceuticals’s sales growth is negative 36.1% for the present quarter and negative 17.8% for the next.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 3.4% and positive 46% for the next.
More news about Inovio Pharmaceuticals.
5. Orange (ORAN) – Premarket: 2.49%
Orange S.A. provides various fixed telephony and mobile telecommunications, data transmission, and other value-added services to customers, businesses, and other telecommunications operators in France and internationally. It operates through France; Spain and Other European Countries; The Africa and Middle East; Enterprise; International Carriers & Shared Services; and Mobile Financial Services segments. The company offers mobile services, such as voice, SMS, and data; fixed broadband and narrowband services, as well as fixed network business solutions, including voice and data; and convergence packages. It also sells mobile handsets, mobile terminals, broadband equipment, connected devices, and accessories. In addition, the company provides IT and integration services comprising unified communication and collaboration services, such as LAN and telephony, consultancy, integration, and project management; hosting and infrastructure services, including cloud computing; customer relations management and other applications services; security services; and video conferencing, as well as sells related equipment. Further, it offers national and international roaming services; online advertising services; and mobile virtual network operators, network sharing, and mobile financial services, as well as sells equipment to external distributors and brokers. The company markets its products and services under the Orange brand. The company was formerly known as France Telecom and changed its name to Orange S.A. in July 2013. Orange S.A. was founded in 1990 and is headquartered in Issy-les-Moulineaux, France.
NYSE ended the session with Orange rising 0.77% to $10.46 on Tuesday, after four successive sessions in a row of gains. NYSE rose 0.89% to $16,052.25, after two successive sessions in a row of gains, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, Orange has a trailing twelve months EPS of $2.06.
PE Ratio
Orange has a trailing twelve months price to earnings ratio of 5.09. Meaning, the purchaser of the share is investing $5.09 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.23%.
Moving Average
Orange’s worth is higher than its 50-day moving average of $10.08 and under its 200-day moving average of $10.59.
Volatility
Orange’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.52%, a negative 0.13%, and a positive 0.93%.
Orange’s highest amplitude of average volatility was 0.82% (last week), 0.91% (last month), and 0.93% (last quarter).
More news about Orange.
6. Aurora Cannabis (ACB) – Premarket: 1.63%
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, Caribbeans, South America, and Israel; and distribution and sale of hemp-derived cannabidiol (CBD) products in the United States (U.S.) market. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, and cannabis extracts, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried milled strains and strain specific cannabis oils. Further, it offers patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
NYSE ended the session with Aurora Cannabis jumping 0.32% to $0.91 on Tuesday, after two consecutive sessions in a row of gains. NYSE jumped 0.89% to $16,052.25, after two successive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, Aurora Cannabis has a trailing twelve months EPS of $-15.749.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.38%.
More news about Aurora Cannabis.
7. Ericsson (ERIC) – Premarket: 1.58%
Telefonaktiebolaget LM Ericsson (publ), together with its subsidiaries, provides communication infrastructure, services, and software solutions to the telecom and other sectors. It operates through four segments: Networks, Digital Services, Managed Services, and Emerging Business and Other. The Networks segment offers radio access network solutions for various network spectrum bands, including integrated high-performing hardware and software. This segment also provides integrated antenna and transport solutions; and a range of service portfolio covering network deployment and support. The Digital Services segment offers software-based solutions for business support systems, operational support systems, communication services, core networks, and cloud infrastructure. The Managed Services segment provides networks and IT managed, network design and optimization, and application development and maintenance services to telecom operators. The Emerging Business and Other segment includes emerging businesses comprising Internet of Things; iconectiv; Cradlepoint that offers wireless edge WAN 4G and 5G enterprise solutions; and Red Bee Media, MediaKind, and other new businesses. It operates in North America, Europe and Latin America, the Middle East and Africa, South East Asia, Oceania, India, North East Asia, and internationally. Telefonaktiebolaget LM Ericsson (publ) was founded in 1876 and is headquartered in Stockholm, Sweden.
NASDAQ ended the session with Ericsson dropping 0.26% to $5.68 on Tuesday, after two consecutive sessions in a row of losses. NASDAQ rose 1.48% to $11,891.79, following the last session’s upward trend on what was an all-around up trend exchanging session today.
Earnings Per Share
As for profitability, Ericsson has a trailing twelve months EPS of $-0.72.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.9%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 50% and a negative 42.9%, respectively.
Volatility
Ericsson’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.53%, a negative 0.35%, and a positive 1.65%.
Ericsson’s highest amplitude of average volatility was 0.62% (last week), 1.50% (last month), and 1.65% (last quarter).
Moving Average
Ericsson’s value is below its 50-day moving average of $6.02 and way under its 200-day moving average of $6.78.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Ericsson’s stock is considered to be overbought (>=80).
More news about Ericsson.
8. CarMax (KMX) – Premarket: 1.58%
CarMax, Inc., together with its subsidiaries, operates as a retailer of used vehicles in the United States. The company operates through two segments, CarMax Sales Operations and CarMax Auto Finance. It offers customers a range of makes and models of used vehicles, including domestic, imported, and luxury vehicles, as well as hybrid and electric vehicles; and extended protection plans to customers at the time of sale, as well as sells vehicles that are approximately 10 years old and has more than 100,000 miles through wholesale auctions. The company also provides reconditioning and vehicle repair services; and financing alternatives for retail customers across a range of credit spectrum through its CarMax Auto Finance and arrangements with various financial institutions. As of February 28, 2022, it operated approximately 230 used car stores. CarMax, Inc. was founded in 1993 and is based in Richmond, Virginia.
NYSE ended the session with CarMax rising 2.08% to $75.10 on Tuesday while NYSE rose 0.89% to $16,052.25.
Earnings Per Share
As for profitability, CarMax has a trailing twelve months EPS of $4.52.
PE Ratio
CarMax has a trailing twelve months price to earnings ratio of 16.62. Meaning, the purchaser of the share is investing $16.62 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.86%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 22.4%, now sitting on 33.05B for the twelve trailing months.
More news about CarMax.
9. Lloyds Banking Group (LYG) – Premarket: 1.56%
Lloyds Banking Group plc, together with its subsidiaries, provides a range of banking and financial services in the United Kingdom. It operates through three segments: Retail; Commercial Banking; and Insurance and Wealth. The Retail segment offers a range of financial service products, including current accounts, savings, mortgages, motor finance, unsecured loans, leasing solutions, and credit cards to personal and small business customers. The Commercial Banking segment provides lending, transactional banking, working capital management, risk management, debt financing, and debt capital market services to small and medium-sized entities, corporates, and financial institutions. The Insurance and Wealth segment offers insurance, investment and wealth management products and services. It also provides digital banking services. The company offers its products and services under the Lloyds Bank, Halifax, Bank of Scotland, and Scottish Widows brands. Lloyds Banking Group plc was founded in 1695 and is based in London, the United Kingdom.
NYSE ended the session with Lloyds Banking Group rising 0.38% to $2.57 on Tuesday, following the last session’s upward trend. NYSE rose 0.89% to $16,052.25, after two sequential sessions in a row of gains, on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, Lloyds Banking Group has a trailing twelve months EPS of $0.0003.
PE Ratio
Lloyds Banking Group has a trailing twelve months price to earnings ratio of 7786.67. Meaning, the purchaser of the share is investing $7786.67 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.5%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Aug 4, 2022, the estimated forward annual dividend rate is 0.1 and the estimated forward annual dividend yield is 5.32%.
Yearly Top and Bottom Value
Lloyds Banking Group’s stock is valued at $2.57 at 07:34 EST, way below its 52-week high of $3.00 and way higher than its 52-week low of $1.70.
More news about Lloyds Banking Group.
10. FuboTV (FUBO) – Premarket: 1.45%
fuboTV Inc. operates a live TV streaming platform for live sports, news, and entertainment content in the United States and internationally. Its fuboTV platform allows customers to access content through streaming devices, as well as on SmartTVs, computers, mobile phones, and tablets. The company is headquartered in New York, New York.
NYSE ended the session with FuboTV falling 1.43% to $2.07 on Tuesday, after five sequential sessions in a row of losses. NYSE rose 0.89% to $16,052.25, after two successive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, FuboTV has a trailing twelve months EPS of $-3.735.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -66.53%.
Volatility
FuboTV’s last week, last month’s, and last quarter’s current intraday variation average was a negative 7.83%, a negative 0.26%, and a positive 4.65%.
FuboTV’s highest amplitude of average volatility was 7.83% (last week), 5.63% (last month), and 4.65% (last quarter).
Sales Growth
FuboTV’s sales growth is 102.2% for the ongoing quarter and 99.7% for the next.
More news about FuboTV.
Premarket Losers Today
1. Cronos Group (CRON) – Premarket: -1.75%
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
NASDAQ ended the session with Cronos Group rising 0.66% to $2.29 on Tuesday while NASDAQ rose 1.48% to $11,891.79.
Earnings Per Share
As for profitability, Cronos Group has a trailing twelve months EPS of $-0.212.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.16%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 47.6%, now sitting on 94.3M for the twelve trailing months.
Volatility
Cronos Group’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.71%, a negative 0.55%, and a positive 2.50%.
Cronos Group’s highest amplitude of average volatility was 2.15% (last week), 2.06% (last month), and 2.50% (last quarter).
More news about Cronos Group.
2. Niu Technologies (NIU) – Premarket: -1.5%
Niu Technologies designs, manufactures, and sells smart electric scooters in the People's Republic of China. The company offers NQi, MQi, UQi, and Gova series electric scooters and motorcycles; KQi series electric kick-scooters; NIU Aero and BQi series e-bikes; RQi and TQi series high-performance motorcycles; and YQi series hybrid motorcycles. It also provides accessories and spare parts under the NIU brand name comprising scooter accessories, such as raincoats, gloves, knee pads, storage baskets and tail boxes, smart phone holders, backrests, and locks; lifestyle accessories, which includes T-shirts, coats, sweaters and hoodies, jeans, hats, bags, jewelry, notebook, badges, key chain, and mugs; and performance upgrade components that comprises of upgraded wheels, shock absorbers, brake calipers, and carbon fiber body panels. In addition, the company, through its NIU app, offers online repair request, DIY repairs, service station locator, theft reporting, and smart services, as well as NIU cover, which provides insurance services; NIU Care that offers maintenance and reserve services in offline service stations; and NIU Wash, which provides free wash coupon on a monthly basis. Niu Technologies sells and services its products through city partners and franchised stores, distributors, and third-party e-commerce platforms and the company's online store. As of December 31, 2021, it operated through 338 city partners and 3,108 franchised stores in approximately 239 cities in the People's Republic of China; and 42 distributors in 50 countries internationally. Niu Technologies was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China.
NASDAQ ended the session with Niu Technologies rising 0.21% to $4.67 on Tuesday while NASDAQ rose 1.48% to $11,891.79.
Earnings Per Share
As for profitability, Niu Technologies has a trailing twelve months EPS of $0.331.
PE Ratio
Niu Technologies has a trailing twelve months price to earnings ratio of 14.11. Meaning, the purchaser of the share is investing $14.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.34%.
Sales Growth
Niu Technologies’s sales growth for the next quarter is negative 22.5%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 12.4%, now sitting on 3.62B for the twelve trailing months.
Moving Average
Niu Technologies’s worth is under its 50-day moving average of $5.13 and way under its 200-day moving average of $5.73.
More news about Niu Technologies.
3. Lumen Technologies (LUMN) – Premarket: -1.23%
Lumen Technologies, Inc., a facilities-based technology and communications company, provides various integrated products and services under the Lumen, Quantum Fiber, and CenturyLink brands to business and residential customers in the United States and internationally. The company operates in two segments, Business and Mass Markets. It offers compute and application services, such as cloud services, IT solutions, unified communication and collaboration solutions, colocation and data center services, content delivery services, and managed security services; and IP and data services, including VPN data network, Ethernet, internet protocol (IP), and voice over internet protocol. The company also provides fiber infrastructure services comprising high bandwidth optical wavelength networks; and unlit optical fiber and related professional services. In addition, it offers voice and other services, including private line services, a direct circuit or channel specifically dedicated for connecting two or more organizational sites; a portfolio of traditional time division multiplexing voice services; and synchronous optical network-based Ethernet, legacy data hosting services, and conferencing services. As of December 31, 2021, the company served approximately 4.5 million broadband subscribers. The company was formerly known as CenturyLink, Inc. and changed its name to Lumen Technologies, Inc. in September 2020. Lumen Technologies, Inc. was incorporated in 1968 and is headquartered in Monroe, Louisiana.
NYSE ended the session with Lumen Technologies rising 2.4% to $4.06 on Tuesday while NYSE rose 0.89% to $16,052.25.
Earnings Per Share
As for profitability, Lumen Technologies has a trailing twelve months EPS of $-0.709.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.68%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 5.4%, now sitting on 19.69B for the twelve trailing months.
Volatility
Lumen Technologies’s last week, last month’s, and last quarter’s current intraday variation average was a negative 7.09%, a negative 2.16%, and a positive 2.84%.
Lumen Technologies’s highest amplitude of average volatility was 8.54% (last week), 4.32% (last month), and 2.84% (last quarter).
More news about Lumen Technologies.
4. Amicus Therapeutics (FOLD) – Premarket: -0.71%
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzyme replacement therapies for Pompe diseases; CLN3, which is in Phase 1/2 clinical study to evaluate the safety and efficacy of a single intrathecal administration of an AAV serotype AT-GTX-502 gene therapy in patients with CLN3; and CDKL5, a gene on the X-chromosome encoding the CDKL5 protein that regulates the expression of essential proteins for normal brain development. The company has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.
NASDAQ ended the session with Amicus Therapeutics jumping 0.48% to $12.64 on Tuesday, following the last session’s upward trend. NASDAQ jumped 1.48% to $11,891.79, following the last session’s upward trend on what was an all-around positive trend exchanging session today.
Earnings Per Share
As for profitability, Amicus Therapeutics has a trailing twelve months EPS of $-1.07.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -145.09%.
Moving Average
Amicus Therapeutics’s value is above its 50-day moving average of $12.40 and way higher than its 200-day moving average of $10.72.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Amicus Therapeutics’s stock is considered to be oversold (<=20).
More news about Amicus Therapeutics.
5. BCE (BCE) – Premarket: -0.5%
BCE Inc., a telecommunications and media company, provides wireless, wireline, Internet, and television (TV) services to residential, business, and wholesale customers in Canada. The company operates through three segments: Bell Wireless, Bell Wireline, and Bell Media. The Bell Wireless segment offers wireless voice and data communication products and services, as well as consumer electronics products. The Bell Wireline segment offers data, including internet access and Internet protocol television (IPTV), local telephone, and long distance services, as well as other communication services and products; and satellite TV service and connectivity servuces. This segment also buys and sells local telephone, long distance, data, and other services from or to resellers and other carriers. The Bell Media segment provides conventional TV, specialty TV, pay TV, streaming services, digital media services, radio broadcasting services, and out-of-home advertising services. BCE Inc. was founded in 1880 and is headquartered in Verdun, Canada.
NYSE ended the session with BCE jumping 0.52% to $45.83 on Tuesday while NYSE rose 0.89% to $16,052.25.
Earnings Per Share
As for profitability, BCE has a trailing twelve months EPS of $2.21.
PE Ratio
BCE has a trailing twelve months price to earnings ratio of 20.69. Meaning, the purchaser of the share is investing $20.69 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.15%.
More news about BCE.
6. ImmunoGen (IMGN) – Premarket: -0.46%
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeutics; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Fusion Pharmaceuticals Inc.; Debiopharm International SA; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.
NASDAQ ended the session with ImmunoGen sliding 0% to $4.35 on Tuesday, following the last session’s downward trend. NASDAQ jumped 1.48% to $11,891.79, following the last session’s upward trend on what was an all-around bullish trend trading session today.
Earnings Per Share
As for profitability, ImmunoGen has a trailing twelve months EPS of $-0.252.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -100.96%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 38.9% and a negative 47.1%, respectively.
Sales Growth
ImmunoGen’s sales growth is 35.5% for the current quarter and negative 44% for the next.
More news about ImmunoGen.
7. Cigna (CI) – Premarket: -0.19%
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
NYSE ended the session with Cigna rising 0.69% to $298.56 on Tuesday while NYSE rose 0.89% to $16,052.25.
Earnings Per Share
As for profitability, Cigna has a trailing twelve months EPS of $22.96.
PE Ratio
Cigna has a trailing twelve months price to earnings ratio of 13. Meaning, the purchaser of the share is investing $13 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.69%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Cigna’s stock is considered to be oversold (<=20).
Yearly Top and Bottom Value
Cigna’s stock is valued at $298.56 at 07:34 EST, way below its 52-week high of $340.11 and way above its 52-week low of $213.16.
More news about Cigna.
8. Cigna (CI) – Premarket: -0.19%
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
NYSE ended the session with Cigna jumping 0.69% to $298.56 on Tuesday while NYSE jumped 0.89% to $16,052.25.
Earnings Per Share
As for profitability, Cigna has a trailing twelve months EPS of $22.96.
PE Ratio
Cigna has a trailing twelve months price to earnings ratio of 13. Meaning, the purchaser of the share is investing $13 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.69%.
Sales Growth
Cigna’s sales growth is 4.3% for the present quarter and 0.2% for the next.
More news about Cigna.
9. CNH Industrial (CNHI) – Premarket: -0.12%
CNH Industrial N.V. designs, produces, markets, sells, and finances agricultural and construction equipment, trucks, commercial vehicles, buses, and specialty vehicles in North America, Europe, South America, and internationally. It operates through five segments: Agriculture, Construction, Commercial and Specialty Vehicles, Powertrain, and Financial. The Agriculture segment provides farm machinery and implements that include two-and four-wheel drive tractors, crawler tractors, combines, cotton pickers, grape and sugar cane harvesters, hay and forage equipment, planting and seeding equipment, soil preparation and cultivation implements, and material handling equipment under the New Holland Agriculture, Case IH, STEYR, Miller, Kongskilde, Överum, K-Line, and JF brands. The Construction segment offers excavators, crawler dozers, graders, wheel and backhoe loaders, and skid steer and compact track loaders under the CASE Construction and New Holland Construction brands. The Commercial and Specialty Vehicles segment provides light, medium, and heavy vehicles for the transportation and distribution of goods under the IVECO brand; commuter buses and city-buses under the IVECO BUS and Heuliez Bus brands; quarry and mining equipment under the IVECO ASTRA brand; firefighting vehicles under the Magirus brand; and vehicles for civil defense and peace-keeping missions under the Iveco Defence Vehicles brand. The Powertrain segment offers engines, transmission systems, and axles for on- and off-road applications, as well as for marine and power generation under the FPT Industrial brand. The Financial Services segment provides and administers retail financing to customers for the purchase or lease of new and used industrial equipment or vehicles, and other equipment; wholesale financing, which primarily consists of floor plan financing; and trade receivables factoring services. The company was founded in 1842 and is headquartered in London, the United Kingdom.
NYSE ended the session with CNH Industrial jumping 1.14% to $16.41 on Tuesday, after four successive sessions in a row of gains. NYSE rose 0.89% to $16,052.25, after two consecutive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, CNH Industrial has a trailing twelve months EPS of $-0.37.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.72%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 18, 2022, the estimated forward annual dividend rate is 0.29 and the estimated forward annual dividend yield is 2.3%.
Sales Growth
CNH Industrial’s sales growth is negative 26.7% for the current quarter and negative 31.6% for the next.
Volatility
CNH Industrial’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.38%, a negative 0.38%, and a positive 1.22%.
CNH Industrial’s highest amplitude of average volatility was 0.75% (last week), 1.32% (last month), and 1.22% (last quarter).
More news about CNH Industrial.
10. United Airlines (UAL) – Premarket: -0.08%
United Airlines Holdings, Inc., through its subsidiaries, provides air transportation services in North America, Asia, Europe, Africa, the Pacific, the Middle East, and Latin America. The company transports people and cargo through its mainline and regional fleets. It also offers catering, ground handling, training, and maintenance services for third parties. The company was formerly known as United Continental Holdings, Inc. and changed its name to United Airlines Holdings, Inc. in June 2019. United Airlines Holdings, Inc. was incorporated in 1968 and is headquartered in Chicago, Illinois.
NASDAQ ended the session with United Airlines rising 0.67% to $49.19 on Tuesday while NASDAQ jumped 1.48% to $11,891.79.
Earnings Per Share
As for profitability, United Airlines has a trailing twelve months EPS of $-22.68.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -14.56%.
Sales Growth
United Airlines’s sales growth is 49.6% for the current quarter and 45.9% for the next.
Volume
Today’s last reported volume for United Airlines is 3528170 which is 57.27% below its average volume of 8258650.
Volatility
United Airlines’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.79%, a negative 0.25%, and a positive 2.06%.
United Airlines’s highest amplitude of average volatility was 1.15% (last week), 1.61% (last month), and 2.06% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, United Airlines’s stock is considered to be overbought (>=80).
More news about United Airlines.
Stay up to date with our premarket winners and losers daily report
